Detalhe da pesquisa
1.
Enantioselective synthesis of derivatives and structure-activity relationship study in the development of NA255 as a novel host-targeting anti-HCV agent.
Bioorg Med Chem Lett
; 23(1): 336-9, 2013 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23164713
2.
Design and synthesis of novel macrocyclic 2-amino-6-arylpyrimidine Hsp90 inhibitors.
Bioorg Med Chem Lett
; 22(2): 1136-41, 2012 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22192591
3.
Discovery of CH7057288 as an Orally Bioavailable, Selective, and Potent pan-TRK Inhibitor.
J Med Chem
; 65(18): 12427-12444, 2022 09 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36066182
4.
Discovery of [5-Amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone (CH5183284/Debio 1347), An Orally Available and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor.
J Med Chem
; 59(23): 10586-10600, 2016 12 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27933954
5.
Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole.
Bioorg Med Chem Lett
; 13(2): 191-6, 2003 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-12482421